![glp-1 origin Designing delivery: structural perspectives and formulation approaches for optimized therapy glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41387-025-00397-4/MediaObjects/41387_2025_397_Fig1_HTML.png)
glp-1 origin Designing delivery: structural perspectives and formulation approaches for optimized therapy glp-1_analogs [TUSOM | Pharmwiki]
Description
Liraglutide : Commenced at 0.6 mg daily, with weekly increments of 0.6 mg up to the maintenance dose
![glp-1 origin Designing delivery: structural perspectives and formulation approaches for optimized therapy glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Glycaemic improvements in patients with type 2 diabetes taking Wegovy could theoretically reduce UTI risk, as elevated blood glucose levels are associated with increased susceptibility to infections, including UTIs
![glp-1 origin Designing delivery: structural perspectives and formulation approaches for optimized therapy glp-1_analogs [TUSOM | Pharmwiki]](https://www.mdpi.com/molecules/molecules-28-00751/article_deploy/html/images/molecules-28-00751-g002-550.jpg)
Sleep Med Rev 2025
![glp-1 origin Designing delivery: structural perspectives and formulation approaches for optimized therapy glp-1_analogs [TUSOM | Pharmwiki]](https://guides.secondnature.io/wp-content/uploads/2023/11/GLP-1hormone.png)
Knerr PJ, Mowery SA, Finan B, et al
![glp-1 origin Designing delivery: structural perspectives and formulation approaches for optimized therapy glp-1_analogs [TUSOM | Pharmwiki]](https://revolutionhealth.org/cdn/shop/articles/What_is_GLP-1_9e9d1b41-2be6-410c-bc3a-855652d1bef7.png?v=1768865020&width=1100)
